Log In
Print this Print this

DFMO/sulindac, eflornithine/sulindac (CPP-1X/sulindac)

  Manage Alerts
Collapse Summary General Information
Company Cancer Prevention Pharmaceuticals Inc.
DescriptionCombination of eflornithine (difluoromethylornithine, DFMO), a selective inhibitor of ornithine decarboxylase (ODC), and sulindac, a generic NSAID
Molecular Target Ornithine decarboxylase (ODC)
Mechanism of ActionOrnithine decarboxylase (ODC) inhibitor
Therapeutic ModalitySmall molecule: Combination

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
Get a free BioCentury trial today